[Application Protocol of Standardized Neonatal Parenteral Nutrition Formulations]

Sichuan Da Xue Xue Bao Yi Xue Ban. 2022 Sep;53(5):941-944. doi: 10.12182/20220960107.
[Article in Chinese]

Abstract

With the improvements in medical technology, more premature infants and infants with congenital intestinal malformations or other conditions who need parenteral nutrition (PN) support can survive. PN technology has become an important therapeutic strategy in neonatal intensive care units. Due to differences in the qualifications of medical staffs, hospital pharmacy management, hospital level, etc, the composition and preparation methods of PN prescription vary greatly in different regions and hospitals in China. In addition, delays in the starting time of PN, unreasonable formula of nutrition components, poor prescription review, large workload involved in the preparation of PN for nurses, and waste of drugs are prone to happen. In view of these issues, our hospital independently developed standardized formulas of neonatal PN solution, which has been approved in Australia as a patented invention. Herein, we reported the composition and application protocol of this standardized PN solution for newborns.

随着医疗技术的提高,更多的早产儿、先天性肠道畸形等需要肠外营养支持的患儿得以存活,肠外营养技术已成为新生儿重症监护病房中一项重要的治疗手段。受医务人员资质、医院药房管理、医院级别等的影响,国内不同地区、不同医院间肠外营养液处方组成和配制方法差别较大,且易出现肠外营养开始时间延迟、营养成分配比不合理、处方审核不力、护士配液工作量大、药品浪费等情况。鉴于以上各种情况,我院自主开发新生儿标准肠外营养液配方,已获批澳大利亚发明专利,在此介绍这种新生儿标准肠外营养液组成成分和使用规范。

Keywords: Application protocol; Ingredients; Neonates; Parenteral nutrition; Standardization.

Publication types

  • Review

MeSH terms

  • China
  • Drug Compounding
  • Humans
  • Infant
  • Infant, Newborn
  • Infant, Premature*
  • Parenteral Nutrition*

Grants and funding

四川省科技厅应用基础研究项目(No. 2021YJ0171)资助